Pharmaceutical and Biomedical Research
Pharm Biomed Res
Medical Sciences
http://pbr.mazums.ac.ir
1
admin
2423-4486
2423-4494
10.29252/pbr
8888
en
jalali
1399
11
1
gregorian
2021
2
1
7
2
online
1
fulltext
en
Doctors Perception of the Use of Hydroxychloroquine as Prophylaxis for COVID-19 Infection
فارماکولوژی
Pharmacology
پژوهشي
Original Research
<strong>Background</strong>: The National Task force constituted by the Indian Council of Medical Research (ICMR) and various International agencies has recommended the use of Hydroxychloroquine (HCQ) as prophylaxis for Coronavirus Disease 2019 (COVID-19). This measure was taken because of the urgent need to protect high-risk individuals like Health Care Workers (HCW) from contracting COVID-19.<br>
<strong>Objectives</strong>: This study aimed to assess the awareness, attitudes, and practices on using HCQ as prophylaxis to prevent COVID-19 infection.<br>
<strong>Methods</strong>: A cross-sectional study was conducted among the doctors working in Dr RML Hospital, New Delhi, India, a tertiary care public hospital involved in the care of COVID-19 patients. The invitation to participate was electronically circulated, and the consenting participants were allowed to access an online survey. The survey had a total of 23 questions that were designed to understand the awareness, perception, and practices of doctors regarding the use of HCQ as prophylaxis in COVID-19.<br>
<strong>Results</strong>: About 147 doctors participated in this survey. The major source of knowledge regarding HCQ prophylaxis was quoted as regulatory agencies (44%), particularly ICMR, and the main indication was reported as being a healthcare worker (60%). Most of the participants (91%) believed that the HCQ effect is not clear and felt more scientific data regarding the use of HCQ as prophylaxis for COVID-19. But many doctors (51%) still recommend using HCQ to their colleagues. <br>
<strong>Conclusion</strong>: In this study, we observed that most doctors were aware of the recommendations regarding the HCQ prophylaxis in COVID-19 and had good adherence to therapy but felt the need for more concrete scientific evidence for using HCQ.
<div><div></div></div>
COVID-19, Hydroxychloroquine, Prophylaxis
97
104
http://pbr.mazums.ac.ir/browse.php?a_code=A-10-510-2&slc_lang=en&sid=1
Proteesh
Rana
proteesh@gmail.com
10031947532846006621
10031947532846006621
No
Department of Pharmacology, University College of Medical Sciences, Delhi.
Manik
Ghadlinge
manik_ghadlinge@rediffmail.com
10031947532846006622
10031947532846006622
Yes
Department of Medicine, ABVIMS & Dr RML Hospital, New Delhi, India.
Pratap
Singh
drpatapsingh@yahoo.co.in
10031947532846006623
10031947532846006623
No
Department of Pulmonary Medicine & Critical Care, Yashoda Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India.
R. D.
Chandane
drchandanerd@rediffmail.com
10031947532846006624
10031947532846006624
No
Department of Medicine, ABVIMS & Dr RML Hospital, New Delhi, India.
Arjun
Khanna
doc.khanna@gmail.com
10031947532846006625
10031947532846006625
No
Department of Pulmonary Medicine & Critical Care, Yashoda Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India.